Description

Eurepa 1mg Tablet is a medication containing Repaglinide as its active ingredient. It is primarily used in the treatment of type 2 diabetes. Repaglinide is an oral blood glucose-lowering drug that belongs to the class of medications called meglitinides. Eurepa 1mg Tablet works by stimulating the release of insulin from the pancreas, which helps in lowering blood sugar levels. It is usually prescribed for individuals who cannot effectively control their blood sugar levels through diet and exercise alone. The recommended dosage of Eurepa 1mg Tablet is determined by the doctor based on the patient’s condition and response to treatment. It is typically taken before meals, usually within 15 minutes before starting a meal. Regular monitoring of blood sugar levels is important while taking this medication. Common side effects of Eurepa 1mg Tablet may include hypoglycemia (low blood sugar levels), weight gain, and gastrointestinal symptoms like nausea or diarrhea.

Additional information